SI-BONE, Inc. Cash Flow Statement
SIBN / Health Care|9 years of annual SEC 10-K data (FY2017-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 9 fiscal years. All figures from audited SEC 10-K filings.
SI-BONE, Inc. used $675,000 in operating cash flow and negative free cash flow of $9M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.75 (distress zone, below 1.8 threshold)
- Negative profit margin: -18.5%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$18.9M | -$30.9M | -$43.3M | -$61.3M | -$56.6M | -$43.7M | -$38.4M | -$17.5M | -$23.0M |
| Depreciation & Amortization | $5.8M | $4.4M | $5.4M | $3.5M | $2.1M | $1.1M | $774.0K | $722.0K | $1.0M |
| Operating Cash Flow | -$675.0K | -$12.4M | -$18.7M | -$41.7M | -$39.5M | -$30.7M | -$31.6M | -$14.5M | -$17.5M |
| Capital Expenditures | $8.4M | $10.5M | $7.8M | $9.5M | $6.4M | $2.6M | $2.4M | $942.0K | $478.0K |
| Free Cash Flow | -$9.1M | -$22.9M | -$26.5M | -$51.2M | -$45.9M | -$33.2M | -$34.1M | -$15.5M | -$18.0M |
| Share Buybacks | - | - | - | - | - | - | $38.0K | $73.0K | $0 |
| FCF Margin | -4.5% | -13.7% | -19.1% | -48.1% | -50.9% | -45.3% | -50.6% | -27.9% | -37.5% |